Kueffer Thomas, Panakal Ajay, Herrera Claudia, Tanner Hildegard, Servatius Helge, Roten Laurent, Reichlin Tobias
Department of Cardiology, Inselspital, Bern University Hospital, University of Bern, Freiburgstrasse, 3600 Bern, Switzerland.
Johnson & Johnson MedTech, Switzerland.
Eur Heart J Case Rep. 2025 May 12;9(6):ytaf231. doi: 10.1093/ehjcr/ytaf231. eCollection 2025 Jun.
Accurate electroanatomical mapping relies on voltage thresholds to differentiate electrically inactive areas, fibrotic scar, and healthy myocardium. These thresholds have been well established for high-density mapping catheters with small, closely spaced electrodes. However, the optimal voltage thresholds for a novel pulsed-field ablation catheter with integrated mapping capabilities remain unclear. This case series evaluates different voltage thresholds for the variable-loop circular catheter (VLCC, Varipulse, Biosense Webster) compared with a dedicated high-density mapping catheter (Octaray, Biosense Webster).
Four patients undergoing left atrial catheter ablation-including pulmonary vein isolation (PVI), posterior wall ablation, and ablation for scar-related atrial flutter-were mapped using both the VLCC and Octaray catheter. The key findings include: (i) standard voltage thresholds for high-density catheters overestimate voltage in scarred and ablated tissue when applied to the VLCC, necessitating adjusted voltage settings; (ii) the VLCC effectively identified PVI and reconnections, posterior wall isolation, anterior wall scarring, and atrial flutter circuits; and (iii) while the VLCC identified areas of scar, its representation remained less precise compared with high-density mapping.
This case series demonstrates that the VLCC provides satisfactory mapping performance in common use cases but requires voltage threshold adjustments for accurate visualization. Despite its ability to detect ablation endpoints, scar characterization remains less accurate. Further quantitative analysis of electrogram differences and a prospective evaluation in a larger patient population are necessary to determine the optimal voltage thresholds for this catheter.
精确的电解剖标测依赖电压阈值来区分电静止区域、纤维化瘢痕和健康心肌。这些阈值已在具有小且间距紧密电极的高密度标测导管中得到充分确立。然而,对于具有集成标测功能的新型脉冲场消融导管而言,最佳电压阈值仍不明确。本病例系列评估了可变环圆形导管(VLCC,Varipulse,Biosense Webster)与专用高密度标测导管(Octaray,Biosense Webster)相比的不同电压阈值。
4例接受左心房导管消融(包括肺静脉隔离、后壁消融以及瘢痕相关房扑消融)的患者使用VLCC和Octaray导管进行了标测。主要发现包括:(i)当将高密度导管的标准电压阈值应用于VLCC时,会高估瘢痕组织和消融组织中的电压,因此需要调整电压设置;(ii)VLCC能有效识别肺静脉隔离及重新连接、后壁隔离、前壁瘢痕形成以及房扑环路;(iii)虽然VLCC能识别瘢痕区域,但其显示与高密度标测相比仍不够精确。
本病例系列表明,VLCC在常见应用病例中提供了令人满意的标测性能,但为实现精确可视化需要调整电压阈值。尽管其能够检测消融终点,但瘢痕特征的识别仍不够准确。有必要对心电图差异进行进一步定量分析,并在更大患者群体中进行前瞻性评估,以确定该导管的最佳电压阈值。